Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06311110

Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD

This cross-sectional case-control study aimed to determine whether there is a significant difference in the prevalence of impaired toilet training, LUTS, and functional bowel problems among children diagnosed with DCD and typically developing children (TDC).

Recruiting

Interested in participating?

Request Info

Key information

Age range

5 year–8 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ghent University Hospital/Ghent University, Ghent, East Flanders, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with DCD by a multidisciplinary team (DCD case group)
  • Children with a typical development, grade and gender matched with the DCD case group (TDC control group).

Exclusion criteria

  • A DCD-Q score indicative for DCD (TDC control group)
  • Presence of other developmental disorders, such as ASS, ADHD or intellectual disability (TDC control group)

Treatment and study plan

Vancouver symptom score for dysfunctional elimination symptoms Questionnaire

Other

Vancouver symptom score for dysfunctional elimination syndrome, Dutch version, validated by 't Hoen et al. 2016. The questionnaire is filled in by the parents of the child.

Other names: VSSDES

Developmental Coordination Disorder Questionnaire

Other

Validated Developmental Coordination Disorder Questionnaire, Dutch version includes assessment of motor functioning. The questionnaire is filled in by the parents of the child.

Other names: DCD-Q, CVO

Questionnaire concerning impaired toilettraining and comorbities

Other

Unvalidated, complementary questions concerning impaired toilettraining and comorbidities. Questions were based on ICCS standardisation guidelines (Austin et al., 2015). The questionnaire is filled in by the parents of the child.

Primary outcomes

  1. Impaired toilet training

    Time frame: through study completion, 25 minutes

    Prevalence of impaired toilet training in children with DCD compared to TDC

  2. Daytime incontinence

    Time frame: through study completion, 25 minutes

    Prevalence of daytime incontinence at 5 years old in children with DCD compared to TDC

  3. Enuresis

    Time frame: through study completion, 25 minutes

    Prevalence of enuresis at 5 years old in children with DCD compared to TDC

  4. Fecal incontinence

    Time frame: through study completion, 25 minutes

    Prevalence of fecal incontinence at 4 years old in children with DCD compared to TDC

Secondary outcomes

  1. Toilet training difficulties

    Time frame: through study completion, 25 minutes

    Prevalence and amount of toilet training difficulties in children with DCD compared to TDC

  2. General bladder and bowel dysfunction

    Time frame: through study completion, 25 minutes

    Prevalence of LUTS, bowel problems or combined bladder and bowel dysfunction in children with DCD compared to TDC

Study contacts

Contact information is provided by the study sponsor or research team.

Bieke Samijn, PhD

CONTACT

[email protected]

+32 9 332 19 38

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Official study title

Impaired Toilet Training, Lower Urinary Tract Symptoms and Bowel Dysfunction in Children With Developmental Coordination Disorder

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Mar 15, 2024
Registry last updated
Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.